A Respiratory Syncytial Virus Attachment Gene Variant Associated with More Severe Disease in Infants Decreases Fusion Protein Expression, Which May Facilitate Immune Evasion
Stacey Human, Anne L. Hotard, Christina A. Rostad, Sujin Lee, Louise McCormick, Emma K. Larkin, Teresa C. T. Peret, Jaume Jorba, Joseph Lanzone, Tebeb Gebretsadik, John V. Williams, Melissa H. Bloodworth, Matthew T. Stier, Kecia N. Carroll, R. Stokes Peebles, Larry J. Anderson, Tina V. Hartert, Martin L. Moore
Abstract
Strain-specific differences in respiratory syncytial virus (RSV) isolates are associated with differential pathogenesis in mice. However, the role of RSV genotypes in human infection is incompletely understood. This work demonstrates that one such genotype, 2stop+A4G, present in the RSV attachment (G) gene terminus is associated with greater infant disease severity. The genotype consists of two tandem stop codons preceding an A-to-G point mutation in the 4th position of the G gene end transcription termination signal. Virologically, the 2stop+A4G RSV genotype results in reduced levels of the RSV fusion (F) glycoprotein. A recombinant 2stop+A4G RSV was better able to establish infection in the presence of existing RSV immunity than a virus harboring the common A4G mutation. These data suggest that regulation of G and F expression has implications for virulence and, potentially, immune evasion.